Vaishali Pharma Q3 Results
- BSE: -
- NSE: VAISHALI
- ISIN: INE972X01022
- Sector: Biotechnology & Drugs
BSE
This stock is not traded on BSE
NSE
12.90
0.36 (2.87%)
0.36 (2.87%)Volume1.76 M
Updated: Wed 16 Jul, 2025 | 15:29:48
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Vaishali Pharma Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 26.67 | 18.49 | 44.26% | 25.07 | 6.40% |
| Depreciation/ Amortization | 0.12 | 0.12 | 0.00% | 0.12 | -1.93% |
| Operating Income | 1.24 | 2.30 | -45.86% | 2.83 | -56.01% |
| Net Income | 1.44 | 1.97 | -26.71% | 2.11 | -31.70% |
| Other Operating Expenses Total | 2.18 | 0.94 | 132.21% | 0.45 | 385.22% |
| Net Income Before Taxes | 1.93 | 2.63 | -26.71% | 2.86 | -32.69% |
| Total Revenue | 27.91 | 20.79 | 34.30% | 27.90 | 0.07% |
| Selling/ General/ Admin Expenses Total | 0.63 | 0.62 | 1.20% | 0.56 | 11.63% |
| Diluted Normalized EPS | 0.98 | 1.51 | -35.10% | 0.19 | 418.52% |